Blau Farmacêutica Future Growth
Future criteria checks 4/6
Blau Farmacêutica is forecasted to grow earnings and revenue by 16.8% and 18.4% per annum respectively. EPS is expected to grow by 15%. Return on equity is forecast to be 20.8% in 3 years.
Key information
16.8%
Earnings growth rate
15.0%
EPS growth rate
| Biotechs earnings growth | 19.9% |
| Revenue growth rate | 18.4% |
| Future return on equity | 20.8% |
| Analyst coverage | Good |
| Last updated | 11 May 2023 |
Recent future growth updates
Recent updates
What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates
May 14
Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next
Feb 24Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely
Oct 14Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)
Aug 17Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 2,372 | 581 | N/A | N/A | 6 |
| 12/31/2024 | 2,079 | 474 | 65 | 433 | 6 |
| 12/31/2023 | 1,601 | 382 | -7 | 456 | 3 |
| 3/31/2020 | 1,008 | 203 | 103 | 217 | N/A |
| 12/31/2019 | 978 | 200 | 125 | 221 | N/A |
| 9/30/2019 | 987 | 186 | 72 | 131 | N/A |
| 6/30/2019 | 938 | 177 | 24 | 82 | N/A |
| 3/31/2019 | 819 | 129 | 19 | 77 | N/A |
| 12/31/2018 | 782 | 123 | 32 | 83 | N/A |
| 9/30/2018 | 677 | 90 | 27 | 67 | N/A |
| 6/30/2018 | 616 | 78 | 62 | 90 | N/A |
| 3/31/2018 | 634 | 110 | 104 | 137 | N/A |
| 12/31/2017 | 618 | 103 | 90 | 127 | N/A |
| 12/31/2016 | 431 | 32 | N/A | 46 | N/A |
| 12/31/2015 | 379 | 22 | N/A | 42 | N/A |
| 12/31/2014 | 299 | 17 | N/A | 14 | N/A |
| 12/31/2013 | 271 | 15 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BLAU3's forecast earnings growth (16.8% per year) is above the savings rate (9.7%).
Earnings vs Market: BLAU3's earnings (16.8% per year) are forecast to grow faster than the BR market (11.6% per year).
High Growth Earnings: BLAU3's earnings are forecast to grow, but not significantly.
Revenue vs Market: BLAU3's revenue (18.4% per year) is forecast to grow faster than the BR market (6.1% per year).
High Growth Revenue: BLAU3's revenue (18.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BLAU3's Return on Equity is forecast to be high in 3 years time (20.8%)